Global timing of hepatitis C virus elimination in high‐income countries-Reference-Cited by-同舟云学术

Global timing of hepatitis C virus elimination in high‐income countries

Published:2019-12-23 Issue:3 Volume:40 Page:522-529
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Razavi Homie¹^ORCID,Sanchez Gonzalez Yuri²,Yuen Cammy³,Cornberg Markus⁴^ORCID

Affiliation:

1. Center for Disease Analysis Lafayette CO United States

2. AbbVie Inc. North Chicago IL United States

3. AbbVie Ltd. Mascot NSW Australia

4. Department of Gastroenterology, Hepatology and Endocrinology Medizinische Hochschule Hannover Hannover Germany

Funder

AbbVie

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14324

Reference19 articles.

1. WHO.Global Health Sector Strategy on Viral Hepatitis 2016–2021 Towards Ending Viral Hepatitis.Geneva Switzerland:Author;2016.

2. Strategies to manage hepatitis C virus (HCV) disease burden

3. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

4. The World Bank. World Bank Country and Lending Groups.2019.https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global epidemiology of liver cancer 2022: An emphasis on geographic disparities;Chinese Medical Journal;2024-09-03

2. Post‐Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia‐Pacific Region;Journal of Viral Hepatitis;2024-08-08

3. Single‐tube, single‐strip lateral flow assays utilizing loop‐mediated isothermal amplification for simultaneous hepatitis B and C viral detection;Journal of Medical Virology;2024-06

4. Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374);Journal of Viral Hepatitis;2024-05-15

5. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02